by Alice Park
… In fact, in the past year, many major pharmaceutical companies have either stopped research on Alzheimer’s treatments after early studies of their drugs failed to show they were effective or decided to move away from developing treatments for neurodegenerative conditions altogether. “The data are pretty soft on a lot of things,” says Dr. Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center, “so that was discouraging for the field and discouraging for the general public.”
Reach: Time magazine covers national and international news and provides analysis and perspective of these events. The weekly magazine has a circulation of 3.2 million readers and its website has 4.3 million unique visitors each month.
Context: Ron Petersen, M.D., Ph.D., is the Cora Kanow Professor of Alzheimer’s Disease Research at Mayo Clinic. Dr. Petersen is regularly sought out by reporters as a leading expert in his medical field. Dr. Petersen chairs the Advisory Council on Alzheimer’s Research, Care and Services.
Contact: Susan Barber Lindquist